SCYNEXIS to Present at Upcoming Investor Conferences
August 31 2017 - 9:05AM
SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company delivering
innovative anti-infective therapies for difficult-to-treat and
often life-threatening infections, today announced that the Company
will present at the following upcoming investor conferences:
- Baird’s 2017 Global Healthcare Conference at the
InterContinental New York Barclay Hotel on Thursday, September 7,
2017 at 8:30 a.m. ET.
- The Rodman & Renshaw 19th Annual Global Investment
Conference at the Lotte New York Palace Hotel on Monday, September
11, 2017 at 9:35 a.m. ET.
- The Cantor Fitzgerald 2017 Global Healthcare Conference at the
InterContinental New York Barclay Hotel on Wednesday, September 27,
2017 at 11:30 a.m. ET.
Live webcasts of each presentation will be available on the
investors section of the Company’s website: www.SCYNEXIS.com.
Replays of each presentation will be available approximately two
hours after each event and will be available for two weeks
following each presentation.
About SCYNEXISSCYNEXIS, Inc. is a biotechnology
company committed to positively impacting the lives of
patients suffering from difficult-to-treat and often
life-threatening infections by delivering innovative anti-infective
therapies. The SCYNEXIS team has extensive experience in the life
sciences industry, discovering and developing more than 30
innovative medicines over a broad range of therapeutic areas. The
Company's lead product candidate, SCY-078, is the first
representative of a novel intravenous and oral triterpenoid
antifungal family and is in Phase 2 clinical development for the
treatment of several fungal infections, including serious and
life-threatening invasive fungal infections. For more
information, visit www.scynexis.com.
CONTACT:
Media Relations
Cammy Duong
MacDougall Biomedical Communications
Tel: 781-591-3443
cduong@macbiocom.com
Investor Relations
Susan Kim
Argot Partners
Tel: 212-203-4433
susan@argotpartners.com
Scynexis (NASDAQ:SCYX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Scynexis (NASDAQ:SCYX)
Historical Stock Chart
From Apr 2023 to Apr 2024